Top compounds associated with response to PFDN4


Feature Type Standardized
Nominal ANOVA
mRNA OSI-930 CTRPv2 pan-cancer AAC -0.08 0.03
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Bortezomib FIMM pan-cancer AAC -0.31 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA etoposide CTRPv2 pan-cancer AAC -0.064 0.03
mRNA neratinib CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.066 0.03
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.066 0.03
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.072 0.03
mRNA PX-12 CTRPv2 pan-cancer AAC -0.06 0.03
Download CSV